11 – 20 of 45
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
- Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD) (
- ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura. (
- Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD) (
- Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura (
- 2006
- Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD (
- A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD) (
- Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor (
- Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome. (
- 2005
- VWF-cleaving protease (ADAMTS13) in premature infants. (
- 2004
- Sorting of Von Willebrand factor to lysosome-related granules of haematopoietic cells (